The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 11869751)

Published in J Affect Disord on December 01, 2001

Authors

G S Leverich1, W A Nolen, A J Rush, S L McElroy, P E Keck, K D Denicoff, T Suppes, L L Altshuler, R Kupka, K G Kramlinger, R M Post

Author Affiliations

1: Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892-1272, USA. levericg@inta.nimh.nih.gov

Articles citing this

Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use. PLoS One (2010) 0.91

Electronic self-monitoring of mood using IT platforms in adult patients with bipolar disorder: A systematic review of the validity and evidence. BMC Psychiatry (2016) 0.90

Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data? MedGenMed (2005) 0.82

Saving time and money: a validation of the self ratings on the prospective NIMH Life-Chart Method (NIMH-LCM). BMC Psychiatry (2014) 0.81

Validation of life-charts documented with the personal life-chart app - a self-monitoring tool for bipolar disorder. BMC Psychiatry (2015) 0.79

A Network Approach to Bipolar Symptomatology in Patients with Different Course Types. PLoS One (2015) 0.79

The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder. BMC Psychiatry (2010) 0.78

Inflammatory monocyte gene expression: trait or state marker in bipolar disorder? Int J Bipolar Disord (2015) 0.78

Comparison of Demographic and Diagnostic Characteristics of Iranian Inpatients With Bipolar I Disorder to Western Counterparts. Iran J Psychiatry Behav Sci (2015) 0.78

Collaborative care for patients with bipolar disorder: a randomised controlled trial. BMC Psychiatry (2011) 0.78

Can variation in hypothalamic-pituitary-adrenal (HPA)-axis activity explain the relationship between depression and cognition in bipolar patients? PLoS One (2012) 0.77

Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses. Int J Bipolar Disord (2015) 0.77

The influence of life events on first and recurrent admissions in bipolar disorder. Int J Bipolar Disord (2015) 0.76

Does the number of previous mood episodes moderate the relationship between alcohol use, smoking and mood in bipolar outpatients? BMC Psychiatry (2017) 0.75

Treatment of bipolar disorder in the Netherlands and concordance with treatment guidelines: study protocol of an observational, longitudinal study on naturalistic treatment of bipolar disorder in everyday clinical practice. BMC Psychiatry (2014) 0.75

Electronic monitoring of self-reported mood: the return of the subjective? Int J Bipolar Disord (2016) 0.75

An actigraphy study investigating sleep in bipolar I patients, unaffected siblings and controls. J Affect Disord (2016) 0.75

Data quality indicators for daily life chart methodology: prospective self-ratings of bipolar disorder and alcohol use. BMC Res Notes (2015) 0.75

The relationship between brain volumes and intelligence in bipolar disorder. J Affect Disord (2017) 0.75

Articles by these authors

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry (1991) 8.37

Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21

Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv (2001) 4.93

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med (2004) 4.89

Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry (1993) 4.57

Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48

The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res (1997) 4.04

Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry (1997) 3.71

Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56

Flexible treatment strategies in chronic disease: clinical and research implications. Biol Psychiatry (2000) 3.21

Psychiatric features of individuals with problematic internet use. J Affect Disord (2000) 3.19

Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02

Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry (2000) 2.88

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA (1994) 2.74

Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70

The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. Psychiatr Serv (1999) 2.68

Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry (1996) 2.53

Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry (1995) 2.53

Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry (2000) 2.52

Redefining the role of psychiatry in medicine. Am J Psychiatry (1996) 2.45

The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38

When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry (1997) 2.35

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34

Compulsive buying: a report of 20 cases. J Clin Psychiatry (1994) 2.29

Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry (1995) 2.26

Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry (1998) 2.23

ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT (2001) 2.21

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry (1998) 2.13

Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry (1989) 2.07

Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport (1995) 2.06

[The Depression Recognition Scale: and aid in the diagnosis of depression in family practice]. Ned Tijdschr Geneeskd (1996) 2.02

Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry (2010) 1.94

Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry (1989) 1.94

Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry (2001) 1.93

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med (2009) 1.91

12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry (1998) 1.91

Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol (1989) 1.91

Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry (2001) 1.88

Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry (1978) 1.88

Characteristics of 34 adults with psychogenic excoriation. J Clin Psychiatry (1998) 1.86

Increasing effects of repetitive cocaine administration in the rat. Nature (1976) 1.85

The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry (1999) 1.84

St John's wort as an antidepressant. BMJ (1996) 1.81

Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs (2001) 1.74

CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry (2001) 1.71

Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69

Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry (2000) 1.66

Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry (2000) 1.66

Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand (2009) 1.66

Workplace performance effects from chronic depression and its treatment. J Health Econ (1998) 1.66

Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry (2010) 1.63

Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry (1996) 1.62

Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry (1999) 1.61

[Undertreatment of depression; causes and recommendations]. Ned Tijdschr Geneeskd (2003) 1.61

Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci (1996) 1.60

Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59

Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med (1992) 1.58

The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry (1999) 1.58

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58

A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull (1994) 1.58

Minimizing and managing antidepressant side effects. J Clin Psychiatry (1995) 1.57

Residual catatonic state following neuroleptic malignant syndrome. J Clin Psychopharmacol (2000) 1.55

Addition of lithium carbonate to carbamazepine: hematological and thyroid effects. Am J Psychiatry (1990) 1.55

Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry (1996) 1.54

Obsessive compulsive spectrum disorder. J Clin Psychiatry (1994) 1.54

Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry (1998) 1.53

The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry (2001) 1.53